Clinical Trial

GLP1 Analogues and the Risk of Osteoarthritis

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Assessing the effects of GLP1 RA Vs SGLT2 Inhibitors vs. Standard of care in joint pain, physical function, stiffness, and improving Quality of Life for patients with type 2 diabetes.
Trial Details
NCT Number NCT07360457
Lead Sponsor Beni-Suef University
Conditions Osteoarthritis
Enrollment 390 participants
Start Date 2026-02-01
Primary Completion 2026-12-01 (estimated)
Study Completion 2027-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-22